HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests
- PMID: 40210699
- PMCID: PMC11985973
- DOI: 10.1038/s41598-025-97169-y
HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests
Abstract
To analyze the false-positive results of HIV screening in a women's and children's specialized hospital and discuss the improved effect of the testing algorithm that retesting with two fourth-generation HIV assays to reduce false-positive results. We retrospectively analyzed 380,390 samples tested with Roche Elecsys® HIV combi PT assay from 2020 to 2023. The responsive samples were retested using the Determine HIV Early Detect assay (Abbott Diagnostic) and the Elecsys® HIV DUO assay (Roche Diagnostic). Finally, the supplemental tests were used to confirm whether the sample is true positive. Of the 380,390 samples, 555 were reactive with Roche Elecsys® HIV combi PT assay. After re-testing with the Determine HIV Early Detect assay and Elecsys® HIV DUO assay, the reactive sample was reduced to 256 cases, and finally 122 cases were confirmed as true positive by supplementary tests. The false positive rate was reduced from 0.11 to 0.04%. The median cut-off index (COI) of false positive samples was significantly lower than that of true positive samples. Pregnancy, tumor and infertility are the top three clinical diagnoses of false positive patients (19.92%, 15.23% and 13.67%, respectively). Retested with two different fourth-generation HIV assays can significantly reduce the false positive rate and improve the positive predictive value. False-positive samples still require longer follow-up to rule out HIV infection.
Keywords: Elecsys® HIV DUO assay; False-positive; HIV; Screening tests; Testing algorithm.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Clinical application evaluation of two fourth-generation human immunodeficiency virus (HIV) screening assays in West China Hospital.J Clin Lab Anal. 2015 Mar;29(2):146-52. doi: 10.1002/jcla.21743. Epub 2014 May 5. J Clin Lab Anal. 2015. PMID: 24797498 Free PMC article.
-
The evaluation of low cut-off index values of Elecsys® HIV combi PT assay in predicting false-positive results.J Clin Lab Anal. 2020 Nov;34(11):e23503. doi: 10.1002/jcla.23503. Epub 2020 Aug 25. J Clin Lab Anal. 2020. PMID: 32841422 Free PMC article.
-
Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and -2.J Virol Methods. 2017 Nov;249:143-146. doi: 10.1016/j.jviromet.2017.09.005. Epub 2017 Sep 8. J Virol Methods. 2017. PMID: 28893550
-
HIV misdiagnosis in sub-Saharan Africa: performance of diagnostic algorithms at six testing sites.J Int AIDS Soc. 2017 Jul 3;20(1):21419. doi: 10.7448/IAS.20.1.21419. J Int AIDS Soc. 2017. PMID: 28691437 Free PMC article. Review.
-
[Screening tests combined with p24 antigen and anti-HIV antibodies in early detection of HIV-1].Transfus Clin Biol. 2000 Jun;7 Suppl 1:18s-24s. doi: 10.1016/s1246-7820(00)80011-7. Transfus Clin Biol. 2000. PMID: 10919219 Review. French.
References
-
- UNAIDS. Executive summary — The path that ends AIDS: UNAIDS Global AIDS Update 2023. https://www.unaids.org/en/resources/documents/2023/global-aids-update-20... (2023).
-
- NCAIDS, N. C. S. T. D. & China, C. D. C. Update on the AIDS/STD epidemic in China in December, 2023. Chin. J. AIDS STD. 30, 225 (2024).
-
- Blaich, A. et al. Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and – 2. J. Virol. Methods. 249, 143–146 (2017). - PubMed
-
- Goodhue, T. et al. 4th generation HIV screening in Massachusetts: a partnership between laboratory and program. J. Clin. Virol58, e13–e18 (2013). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical